BioLineRx (BLRX) EPS (Basic) (2013 - 2025)
BioLineRx (BLRX) recorded quarterly EPS (Basic) of -$0.04 in Q4 2025, down 318.6% quarter-over-quarter from -$0.01 in Q3 2025, and down 3084.26% on a YoY basis from $0.0 in Q4 2024.
BioLineRx (BLRX) EPS (Basic) (2013 - 2025) Analysis & Trends
BioLineRx's EPS (Basic) history runs 13 years deep, the most recent figure standing at -$0.04 for Q4 2025.
- In Q4 2025, EPS (Basic) fell 3084.26% year-over-year to -$0.04; the TTM figure through Dec 2025 stood at -$0.09 (up 56.59% YoY), while the FY2025 annual figure was -$0.1, down 927.26% from the prior year.
- EPS (Basic) was -$0.04 for Q4 2025 at BioLineRx, down from -$0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.02 in Q2 2023 to a low of -$0.08 in Q2 2024.
- Historically, EPS (Basic) has averaged -$0.02 across 5 years, with a median of -$0.01 in 2021.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) surged 200.0% in 2022, then plunged 3084.26% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.01 in 2021, then increased by 20.56% to -$0.01 in 2022, then sank by 30.51% to -$0.01 in 2023, then jumped by 114.17% to $0.0 in 2024, then slumped by 3084.26% to -$0.04 in 2025.
- The last three EPS (Basic) figures came in at -$0.04 (Q4 2025), -$0.01 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -0.06 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | -0.01 |
| Mar 31, 2021 | -0.02 |